FIELD: medicine.
SUBSTANCE: method relates to medicine, particularly to dermatology, and can be applied in treatment of psoriasis vulgaris. It involves administration of delta sleep-inducing peptide in the following pattern: 1 ampoule in the morning and evening of 1st and 2nd day of therapy, 1 ampoule in the morning of 3rd, 4th and 5th day. The same dosage is given over a day. Delta sleep-inducing peptide is dissolved before use by boiled water of room temperature in amount of 1 ml. Further one or two drops are instilled to mid-part of nose, to olfactory nerve ending bifurcation zone over 10-20 minutes interval for 21 day.
EFFECT: improved treatment efficiency due to reduced exacerbation duration and significant prolongation of remission period.
2 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING PSORIASIS | 2006 |
|
RU2322255C1 |
| METHOD OF TREATING PSORIASIS VULGARIS | 2011 |
|
RU2472541C1 |
| METHOD OF TREATING PSORIASIS | 2009 |
|
RU2394575C1 |
| METHOD FOR REHABILITATION OF PATIENTS WITH PSORIASIS AT HEALTH RESORT STAGE | 2023 |
|
RU2824251C1 |
| MEANS FOR THERAPY OF TOXIC ENCEPHALOPATHY CAUSED BY CARBON MONOXIDE | 2015 |
|
RU2669779C2 |
| METHOD FOR TREATING ORAL PHLEGMONS | 2005 |
|
RU2290192C2 |
| AGENT FOR BURN DISEASE TREATMENT | 1993 |
|
RU2070054C1 |
| TOOLS FOR CORRECTING THE DESYNCHRONOSIS CAUSED BY A DISTURBANCE IN THE LIGHT REGIME | 2017 |
|
RU2660578C1 |
| AGENT FOR DISEASES ASSOCIATED WITH STRESS-RELATED CONDITIONS IN DISEASES AND DISORDERS IN HUMAN AND ANIMALS, AND ALSO METHOD OF TREATING AND/OR PREVENTING WITH USING SUCH AGENT | 2009 |
|
RU2450823C2 |
| METHOD OF EXTERNAL TREATMENT OF PSORIATIC ONYCHODYSTROPHY | 2011 |
|
RU2462232C1 |
Authors
Dates
2009-03-20—Published
2007-09-20—Filed